{"entity":{"type":"insider","cik":"0001860131","url":"/insider/0001860131","json_url":"/insider/0001860131.json","name":"Audhya Paul K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":28,"first":"2022-08-19","last":"2026-05-27","span_basis":"filed_date"},"name_variants":[{"name":"Audhya Paul K.","source":"filing","n_filings":28,"first_seen":"2022-08-19","last_seen":"2026-05-27"}],"transactions":[{"id":6032234,"accession":"0001860131-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-26-000008","line_url":"/filing/0001860131-26-000008#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2239.0,"shares_display":"2,239","price_per_share":26.7778,"price_display":"26.78","price_state":"stated","total_value":59955.4942,"total_display":"59,955.49","total_whole":"59,955","shares_owned_after":150260.0,"shares_owned_after_display":"150,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-27","scope":"insider"},{"id":5792249,"accession":"0001860131-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-26-000007","line_url":"/filing/0001860131-26-000007#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2685.0,"shares_display":"2,685","price_per_share":26.7844,"price_display":"26.78","price_state":"stated","total_value":71916.114,"total_display":"71,916.11","total_whole":"71,916","shares_owned_after":147499.0,"shares_owned_after_display":"147,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-26","scope":"insider"},{"id":6120581,"accession":"0001860131-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-26-000006","line_url":"/filing/0001860131-26-000006#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1032.0,"shares_display":"1,032","price_per_share":26.76,"price_display":"26.76","price_state":"stated","total_value":27616.32,"total_display":"27,616.32","total_whole":"27,616","shares_owned_after":143934.0,"shares_owned_after_display":"143,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-19","scope":"insider"},{"id":5900414,"accession":"0001860131-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-26-000004","line_url":"/filing/0001860131-26-000004#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2686.0,"shares_display":"2,686","price_per_share":20.2163,"price_display":"20.22","price_state":"stated","total_value":54300.9818,"total_display":"54,300.98","total_whole":"54,301","shares_owned_after":142547.0,"shares_owned_after_display":"142,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-20","scope":"insider"},{"id":5806514,"accession":"0001860131-26-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001860131-26-000003","line_url":"/filing/0001860131-26-000003#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5354.0,"shares_display":"5,354","price_per_share":15.5668,"price_display":"15.57","price_state":"stated","total_value":83344.6472,"total_display":"83,344.65","total_whole":"83,345","shares_owned_after":138983.0,"shares_owned_after_display":"138,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":5806509,"accession":"0001860131-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-26-000002","line_url":"/filing/0001860131-26-000002#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1163.0,"shares_display":"1,163","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":17445.0,"total_display":"17,445.00","total_whole":"17,445","shares_owned_after":133087.0,"shares_owned_after_display":"133,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":5100750,"accession":"0001860131-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001860131-25-000004","line_url":"/filing/0001860131-25-000004#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5296.0,"shares_display":"5,296","price_per_share":13.451,"price_display":"13.45","price_state":"stated","total_value":71236.496,"total_display":"71,236.50","total_whole":"71,236","shares_owned_after":131831.0,"shares_owned_after_display":"131,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4972141,"accession":"0001860131-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860131-25-000002","line_url":"/filing/0001860131-25-000002#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3075.0,"shares_display":"3,075","price_per_share":14.4795,"price_display":"14.48","price_state":"stated","total_value":44524.4625,"total_display":"44,524.46","total_whole":"44,524","shares_owned_after":125877.0,"shares_owned_after_display":"125,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":4807055,"accession":"0001415889-25-023067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023067","line_url":"/filing/0001415889-25-023067#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2336.0,"shares_display":"2,336","price_per_share":13.42,"price_display":"13.42","price_state":"stated","total_value":31349.12,"total_display":"31,349.12","total_whole":"31,349","shares_owned_after":122505.0,"shares_owned_after_display":"122,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":5005515,"accession":"0001415889-25-022964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022964","line_url":"/filing/0001415889-25-022964#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2942.0,"shares_display":"2,942","price_per_share":13.2228,"price_display":"13.22","price_state":"stated","total_value":38901.4776,"total_display":"38,901.48","total_whole":"38,901","shares_owned_after":119841.0,"shares_owned_after_display":"119,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-25","scope":"insider"},{"id":4806877,"accession":"0001415889-25-022305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022305","line_url":"/filing/0001415889-25-022305#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2939.0,"shares_display":"2,939","price_per_share":13.187,"price_display":"13.19","price_state":"stated","total_value":38756.593,"total_display":"38,756.59","total_whole":"38,757","shares_owned_after":116533.0,"shares_owned_after_display":"116,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":5039536,"accession":"0001415889-25-014601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014601","line_url":"/filing/0001415889-25-014601#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2146.0,"shares_display":"2,146","price_per_share":11.3102,"price_display":"11.31","price_state":"stated","total_value":24271.6892,"total_display":"24,271.69","total_whole":"24,272","shares_owned_after":113026.0,"shares_owned_after_display":"113,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4108985,"accession":"0001415889-25-014478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014478","line_url":"/filing/0001415889-25-014478#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2689.0,"shares_display":"2,689","price_per_share":11.8755,"price_display":"11.88","price_state":"stated","total_value":31933.2195,"total_display":"31,933.22","total_whole":"31,933","shares_owned_after":110172.0,"shares_owned_after_display":"110,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-23","scope":"insider"},{"id":4245560,"accession":"0001415889-25-013868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-013868","line_url":"/filing/0001415889-25-013868#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2776.0,"shares_display":"2,776","price_per_share":11.8428,"price_display":"11.84","price_state":"stated","total_value":32875.6128,"total_display":"32,875.61","total_whole":"32,876","shares_owned_after":106611.0,"shares_owned_after_display":"106,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-20","scope":"insider"},{"id":4381873,"accession":"0001415889-25-005615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-005615","line_url":"/filing/0001415889-25-005615#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2394.0,"shares_display":"2,394","price_per_share":10.02,"price_display":"10.02","price_state":"stated","total_value":23987.88,"total_display":"23,987.88","total_whole":"23,988","shares_owned_after":102940.0,"shares_owned_after_display":"102,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":4244825,"accession":"0001415889-25-004772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-004772","line_url":"/filing/0001415889-25-004772#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":9.8242,"price_display":"9.82","price_state":"stated","total_value":30700.625,"total_display":"30,700.62","total_whole":"30,701","shares_owned_after":100334.0,"shares_owned_after_display":"100,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":2864453,"accession":"0001415889-24-027910","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027910","line_url":"/filing/0001415889-24-027910#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2187.0,"shares_display":"2,187","price_per_share":9.8702,"price_display":"9.87","price_state":"stated","total_value":21586.1274,"total_display":"21,586.13","total_whole":"21,586","shares_owned_after":97012.0,"shares_owned_after_display":"97,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-27","scope":"insider"},{"id":2864354,"accession":"0001415889-24-027272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027272","line_url":"/filing/0001415889-24-027272#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8077.0,"shares_display":"8,077","price_per_share":9.2566,"price_display":"9.26","price_state":"stated","total_value":74765.5582,"total_display":"74,765.56","total_whole":"74,766","shares_owned_after":94199.0,"shares_owned_after_display":"94,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2930050,"accession":"0001415889-24-022258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022258","line_url":"/filing/0001415889-24-022258#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2135.0,"shares_display":"2,135","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":26474.0,"total_display":"26,474.00","total_whole":"26,474","shares_owned_after":83745.0,"shares_owned_after_display":"83,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2807113,"accession":"0001415889-24-021970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021970","line_url":"/filing/0001415889-24-021970#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7973.0,"shares_display":"7,973","price_per_share":12.0133,"price_display":"12.01","price_state":"stated","total_value":95782.0409,"total_display":"95,782.04","total_whole":"95,782","shares_owned_after":80880.0,"shares_owned_after_display":"80,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"},{"id":2278598,"accession":"0001415889-24-014004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-014004","line_url":"/filing/0001415889-24-014004#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13175.0,"shares_display":"13,175","price_per_share":11.7645,"price_display":"11.76","price_state":"stated","total_value":154997.2875,"total_display":"154,997.29","total_whole":"154,997","shares_owned_after":70325.0,"shares_owned_after_display":"70,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-21","scope":"insider"},{"id":2188785,"accession":"0001415889-24-004712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-004712","line_url":"/filing/0001415889-24-004712#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14295.0,"shares_display":"14,295","price_per_share":14.115,"price_display":"14.12","price_state":"stated","total_value":201773.925,"total_display":"201,773.92","total_whole":"201,774","shares_owned_after":52886.0,"shares_owned_after_display":"52,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":8585415,"accession":"0001209191-23-056280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-056280","line_url":"/filing/0001209191-23-056280#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7985.0,"shares_display":"7,985","price_per_share":8.2293,"price_display":"8.23","price_state":"stated","total_value":65710.9605,"total_display":"65,710.96","total_whole":"65,711","shares_owned_after":36568.0,"shares_owned_after_display":"36,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":8189498,"accession":"0001209191-23-046825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-046825","line_url":"/filing/0001209191-23-046825#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8020.0,"shares_display":"8,020","price_per_share":10.7288,"price_display":"10.73","price_state":"stated","total_value":86044.976,"total_display":"86,044.98","total_whole":"86,045","shares_owned_after":26023.0,"shares_owned_after_display":"26,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-21","scope":"insider"},{"id":8220555,"accession":"0001209191-23-031291","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-031291","line_url":"/filing/0001209191-23-031291#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2780.0,"shares_display":"2,780","price_per_share":10.1444,"price_display":"10.14","price_state":"stated","total_value":28201.432,"total_display":"28,201.43","total_whole":"28,201","shares_owned_after":13014.0,"shares_owned_after_display":"13,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":8543591,"accession":"0001209191-23-012319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-012319","line_url":"/filing/0001209191-23-012319#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3412.0,"shares_display":"3,412","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":26135.92,"total_display":"26,135.92","total_whole":"26,136","shares_owned_after":9347.0,"shares_owned_after_display":"9,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-23","scope":"insider"},{"id":6788370,"accession":"0001209191-22-058110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058110","line_url":"/filing/0001209191-22-058110#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":722.0,"shares_display":"722","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":3927.68,"total_display":"3,927.68","total_whole":"3,928","shares_owned_after":5946.0,"shares_owned_after_display":"5,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":6672806,"accession":"0001209191-22-046890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046890","line_url":"/filing/0001209191-22-046890#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001860131","owner_name":"Audhya Paul K.","owner_display_name":"Audhya Paul K.","owner_url":"/insider/0001860131","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":725.0,"shares_display":"725","price_per_share":14.9615,"price_display":"14.96","price_state":"stated","total_value":10847.0875,"total_display":"10,847.09","total_whole":"10,847","shares_owned_after":1693.0,"shares_owned_after_display":"1,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":28,"first_seen":"2022-08-19","last_seen":"2026-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001860131","retrieved_at":"2026-08-24T15:51:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}